Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1147 | Neuroendocrinology | ICEECE2012

The incidence of acromegaly in iceland from 1955 through 2010

Hoskuldsdottir G. , Fjalldal S. , Sigurjonsdottir H.

Objective: Acromegaly is a rare disease with multiple serious comorbidities. The aim of this study was to gather information on patients diagnosed with Acromegaly from 1955 through 2010.Materials and methods: Information on patients with pituitary adenomas diagnosed from 1950 has aldready been gathered and and imported to patient journals at the National University Hospital in Iceland. In this retrospective study information on patients diagnosed with Ac...

ea0029p1220 | Obesity | ICEECE2012

Local inflammatory response in adipose tissue dysfunction

Cantini G. , Francalanci M. , Di Franco A. , Baglioni S. , Poli G. , Samavat J. , Querci V. , Liotta F. , Perigli G. , Lucchese M. , Forti G. , Luconi M.

Chronic low-grade inflammatory condition is associated with metabolic pathologies such as obesity. However, the role exerted by local inflammation occurring in different fat depots, such as subcutaneous (SAT) versus visceral (VAT) adipose tissue (AT), is still under evaluation. Aim of the present study was to characterize the inflammatory state in adipose tissue of obese (OB: n=58, mean±S.D. BMI=47±9) vs normoweight (NOR: n=28, mean±...

ea0029p1300 | Paediatric endocrinology | ICEECE2012

Growth and response to rhGH treatment in patients with congenital combined pituitary hormone deficiency younger than 3 years of age

Braslavsky D. , Keselman A. , Bastida G. , Bergada I.

Congenital combined pituitary hormone deficiency (CCPHD) is a rare disease.Although most of them are growth hormone deficient, growth retardation is not always the presenting symptom\. There is no normative data in children younger than 3 years regarding dose and frequency with rhGH treatment. The objective was to evaluate the timing of growth retardation and the first and second year growth response to rhGH compared to the mathematical growth prediction...

ea0029p1320 | Paediatric endocrinology | ICEECE2012

The median age of the onset of puberty in Uzbek boys of Tashkent city

Rakhimova G. , Gilyazetdinov K. , Alimova N. , Akbarov A.

Background: The age of the onset of puberty is much lower today than in the past century, due to the stability of the socio-economic conditions, improved quality of life and overall health of the population.Materials and methods: We examined healthy 818 boys aged from 7 to 18 years, the study was conducted between 2009 and 2011.Boys were examined in three urban districts of Tashkent city (i.e. Mirzo-Ulugbek, Shakhantaur, Yunus-Abad...

ea0029p1396 | Pituitary Clinical | ICEECE2012

The clinical outcome of pituitary adenomas in the cavernous sinus

Marathe C. , Irish G. , Torpy D.

Introduction: Pituitary adenomas with cavernous sinus involvement (CSI) are associated with serious clinical sequelae but are often incompletely excised during surgery. Contradictory viewpoints exist regarding management of residual tumors in the cavernous sinus with some authors suggesting use of adjuvant radiotherapy post-operatively for long term tumor control. But radiotherapy has been associated with hypopituitarism and increased mortality due to cerebrovascular causes. W...

ea0029p1562 | Thyroid (non-cancer) | ICEECE2012

Hypothyroidism is associated with increased intestinally derived lipoprotein particles and postprandial endothelial dysfunction

McGowan A. , Widdowson W. , Boran G. , Gibney J.

Atheroma is accelerated in overt hypothyroidism (OH) and possibly in subclinical-hypothyroidism (SCH), and is not completely explained by increased LDL-cholesterol. There is little data available regarding post-prandial metabolic changes in OH or SCH.Subjects with OH (n=21), SCH (n=28) and age, sex and BMI matched controls (n=50) were studied fasting and for up to 8-h following a mixed-meal. Investigations included apolipoprotein(apo...

ea0029p1593 | Thyroid (non-cancer) | ICEECE2012

Subclinical and overt hyperthyroidism in a long-term iodine sufficient area of Sweden (Gothenburg) 2003–2005

Nystrom H. Filipsson , Jansson S. , Berg G.

Introduction: The incidence of hyperthyroidism is influenced by iodine nutrition. Sweden is a long-term iodine sufficient (IS) area with an iodination fortification program since 1936.Methods: In 2003–2005, all referred cases of subclinical (SH) and overt hyperthyroidism (OH) were registered from a targeted population of 631239 individuals in Gothenburg. Information on age, gender, etiology, smoking, thyroid associated ophtalmopathy (TAO), thyroid h...

ea0029p1753 | Thyroid cancer | ICEECE2012

The cross-talk between estrogen receptor and peroxisome proliferator-activated receptor gamma in thyroid cancer cells

Chu R , van Hasselt C , Chen G

Both of peroxisome proliferator-activated receptor gamma (PPARγ) and estrogen receptor (ER) contribute to the development of thyroid cancer. Previously, the activation of ERα was found to promote the proliferation of thyroid cancer cells, whereas activation of either ERβ or PPARγ resulted in apoptosis of thyroid cancer cells. Furthermore, a transactivation between ER and PPARγ was reported in estrogen-responsive malignancy, such as breast cancer. Howev...

ea0026s8.2 | The biological clock and metabolism | ECE2011

Circadian clock regulation of glucocorticoid synthesis

Kiessling S , Eichele G , Oster H

Under non-stressed conditions adrenal glucocorticoid (GC) secretion shows strong circadian rhythms with blood levels peaking around wake-up time (i.e. in the morning in humans and at the beginning of the night in nocturnal rodents). These diurnal variations are primarily regulated by rhythmic activation of the hypothalamic–pituitary–adrenal (HPA) axis and the secretion of ACTH from the pituitary. While circadian HPA axis activity is ultimately controlled by the circa...

ea0026p276 | Pituitary | ECE2011

Late development of resistance to cabergoline in a giant macroprolactinoma with aggressive carvenous sinus and spheinodal bone invasion

Mlawa G , Deshmukh S , Nasruddin A , Sandeman D

Background: Dopamine agonists (DA) are used as the first-line trearment in patients with macroprolactinomas. Late resistant to DA(cabergoline) therapy may occur. Patient with resistant macroprolactinoma may end up receiving a relative high dose of DA. These patients should be advised to take up radiotherapy option as earlier as possible to avoid the need of high dose dopamine agonist. We present a 63-year-old man who presented in 1999 with visual loss,due to giant macroprolact...